$30.560
-1.137 (-3.72%)At close
VSH News
VSH Events
Mixed Finish for Major Averages as SpaceX Eyes $1T Revenue by 2029
The major averages had a mixed finish on Wednesday as investors weighed another wave of corporate earnings against continued tensions in the Middle East. Technology stocks remain the primary focus after SpaceX and AMD both reported quarterly results that topped expectations, but nevertheless saw their shares fall sharply in premarket trading.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:SpaceXreported, with the company saying there's a "non-zero chance" of reaching $1T in revenue in 2029Disneyreportedbut lower-than-expected revenue for the periodUberreportedand provided a conservative outlook for Q3Eli Lillyreportedand narrowed its FY26 earnings outlookAMDreportedand provided an upbeat outlook for Q3 revenue2. WALL STREET CALLS:Best Buyto Hold at JefferiesBristol Myersto Buy at ArgusBurlington Storesto Neutral at CitiElf Beautyto Outperform at BernsteinTransDigmto Hold at Stifel3. AROUND THE WEB:Google'schief scientist Jeff Dean is leaving the company to launch Discovery Loop, an AI startup focused on automating scientific research, WSJ reportsJeff Smith's Starboard has taken a position in Shake Shack, Bloomberg reportsGooglehas assembled a $200B financing program for Anthropic, with more than $150B tied to TPUs and involving Broadcom, Blackstone, Apollo, Morgan Stanley, and others, FT saysHP, Asus, and Acerhave started using small amounts of DRAM chips from CXMT in their laptops for non-U.S. markets, amid an unprecedented memory shortage, Nikkei Asia reportsAstraZenecaand Bristol Myersare not engaged in merger discussions, ending speculation around a potential $400B pharmaceutical combination, Reuters says4. MOVERS:Digital Turbinewas higher afterand providing guidance for FY26Latham Groupincreased afterand raising its guidance for FY26Bloomin' Brandsand Cricutgained afterVishay Precisionfell afterand providing guidance for Q3Taboolaand SolarEdgewere lower in New York after5. EARNINGS/GUIDANCE:One Stop Systemsand raised its outlook for FY26EVgo, with CEO Badar Khan commenting on "another quarter of solid execution"Vishay, with EPS beating consensusGilat Satelliteand backed its guidance for FY26, with CEO Adi Sfadia calling it "another strong quarter"CVS Healthand raised its outlook for FY26INDEXES:The Dow rose 263.24, or 0.49%, to 54,349.12, the Nasdaq lost 221.55, or 0.83%, to 26,363.44, and the S&P 500 declined 12.97, or 0.17%, to 7,723.55.
Dow Rises Nearly 400 Points as Tech Stocks Remain in Focus
The major averages were mixed near noon, with the Dow up nearly 400 points as investors weigh another wave of corporate earnings against continued geopolitical tensions in the Middle East. Technology stocks remain the primary focus after SpaceX and AMD both reported quarterly results that topped expectations, but nevertheless saw their shares fall sharply in premarket trading.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:SpaceXreported, with the company saying there's a "non-zero chance" of reaching $1T in revenue in 2029Disneyreportedbut lower-than-expected revenue for the periodUberreportedand provided a conservative outlook for Q3Eli Lillyreportedand narrowed its FY26 earnings outlookAMDreportedand provided an upbeat outlook for Q3 revenue2. WALL STREET CALLS:Best Buyto Hold at JefferiesBristol Myersto Buy at ArgusBurlington Storesto Neutral at CitiElf Beautyto Outperform at BernsteinTransDigmto Hold at Stifel3. AROUND THE WEB:Googlehas assembled a $200B financing program for Anthropic, with more than $150B tied to TPUs and involving Broadcom, Blackstone, Apollo, Morgan Stanley, and others, FT saysHP, Asus, and Acerhave started using small amounts of DRAM chips from CXMT in their laptops for non-U.S. markets, amid an unprecedented memory shortage, Nikkei Asia reportsApple'sannual sales in India exceeded $10B last year, demonstrating the surging demand for its devices in the market, Bloomberg reportsAstraZenecaand Bristol Myersare not engaged in merger discussions, ending speculation around a potential $400B pharmaceutical combination, Reuters saysJPMorganCEO Jamie Dimon is personally reaching out to other CEOs of large and major banks, asking them to join an industry group that focuses on addressing risks posed by AI, Reuters reports4. MOVERS:Digital Turbinehigher afterand providing guidance for FY26Latham Groupincreases afterand raising its guidance for FY26Bloomin' Brandsand Cricutgain afterVishay Precisionfalls afterand providing guidance for Q3Taboolaand SolarEdgelower in New York after5. EARNINGS/GUIDANCE:One Stop Systemsand raised its outlook for FY26EVgo, with CEO Badar Khan commenting on "another quarter of solid execution"Vishay, with EPS beating consensusGilat Satelliteand backed its guidance for FY26, with CEO Adi Sfadia calling it "another strong quarter"CVS Healthand raised its outlook for FY26INDEXES:Near midday, the Dow was up 398.75, or 0.74%, to 54,484.63, the Nasdaq was down 144.93, or 0.55%, to 26,440.06, and the S&P 500 was down 8.81, or 0.11%, to 7,727.71.
Vishay Q2 Revenue at $888.58M, Below Consensus
Reports Q2 revenue $888.58M, consensus $895.04M. "For the second quarter, Vishay delivered 9.5% sequential growth to adjusted revenue of $919 million, exceeding the top end of our revenue guidance and representing continued strengthening demand across all end markets, channels and regions," said Joel Smejkel, president and CEO. "Executing as a new company, Vishay 3.0 is focused on supplying our increasing customer count and taking full advantage of the upcycle, outpacing industry growth, while laying the foundation to leverage multi-year demand across all end markets for sustained growth, expanded margins and enhanced stockholder returns."
Company Expects Q3 2026 Revenue of $945M to $975M
The company said, "For the third quarter of 2026, management expects revenues in the range of $945 million and $975 million and a gross profit margin in the range of 24.0% +/- 50 basis points."
JPMorgan and Others Jointly Manage $50-$52 Deal
The deal range was $50.00-$52.00. JPMorgan, Needham, Oppenheimer, Raymond James, TD Cowen and Truist acted as joint book running managers for the offering.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.



